Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.
Start 7-day free trial → Log in

Cavosonstat · N-91115

Other · developed by Nivalis Therapeutics

Phase 1 Most advanced trial (none active)
1 Registered trials

What is Cavosonstat?

Cavosonstat is an investigational drug studied in Drug Interaction Potentiation.

At a glance

Also known as
N-91115
Drug type
Other
Developer
Nivalis Therapeutics, Inc.
In trials of
DVA
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 1
UNII
O2Z8Q22ZE4

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT02500667 Phase 1 Drug Interaction Potentiation Completed DVA

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Drug Interaction Potentiation

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.